| 摘要 |
<p>Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I: or a salt thereof, in which R1, R2, R100, R200, A, A1, B, B1, BG, n, Q and Q1 are substituents described. Also disclosed is the use of compounds of Formula 1 to treat proliferative disorders.</p> |
| 申请人 |
AEGERA THERAPEUTICS INC. |
发明人 |
LAURENT, ALAIN;HEWITT, KIM;MORRIS, STEPHEN;BUREAU, PATRICK;BOUDREAULT, ALAIN;JARVIS, SCOTT;JAQUITH, JAMES, B. |
